Research has shown that DAPA has potential anticancer effects on colon cancer cells expressing SGLT2 but not UGT1A9 because cancer HCT116 cells express SGLT2 but not UGT1A9(Okada et al., 2018). The gene discussed is SLC5A2; the disease is cancer.